Medico Remedies (NSE:MEDICO) Piotroski F-Score: 5 (As of Jun. 27, 2026) — 17% Below Median


NSE:MEDICO Medico Remedies Ltd NSE:MEDICO
87 GF Score
Price ₹40.28
GF Value ₹75.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medico Remedies Piotroski F-Score?

Medico Remedies NSE:MEDICO -1.88% 87 Piotroski F-Score is 5 as of Jun. 27, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates NSE:MEDICO with a GF Score™ of 87/100 and a GF Value™ of ₹75.89 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 981 Drug Manufacturers companies, Medico Remedies ranks better than 61.37% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medico Remedies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Medico Remedies's Piotroski F-Score or its related term are showing as below:

NSE:MEDICO' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Medico Remedies was 8. The lowest was 5. And the median was 6.

Medico Remedies  (NSE:MEDICO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medico Remedies Piotroski F-Score Related Terms


Medico Remedies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medico Remedies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies Piotroski F-Score Chart

Medico Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 8.00 6.00 6.00 5.00

Medico Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 0.00 0.00 5.00

NSE:MEDICO vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medico Remedies Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medico Remedies's Piotroski F-Score falls into.


NSE:MEDICO
87GF Score
Medico Remedies Ltd NSE:MEDICO
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹131 Mil.
Cash Flow from Operations was ₹59 Mil.
Revenue was ₹2,064 Mil.
Gross Profit was ₹550 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (1197.993 + 1534.033) / 2 = ₹1366.013 Mil.
Total Assets at the begining of this year (Mar25) was ₹1,198 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3 Mil.
Total Current Assets was ₹1,289 Mil.
Total Current Liabilities was ₹776 Mil.
Net Income was ₹101 Mil.

Revenue was ₹1,509 Mil.
Gross Profit was ₹426 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (961.953 + 1197.993) / 2 = ₹1079.973 Mil.
Total Assets at the begining of last year (Mar24) was ₹962 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4 Mil.
Total Current Assets was ₹967 Mil.
Total Current Liabilities was ₹570 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medico Remedies's current Net Income (TTM) was 131. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medico Remedies's current Cash Flow from Operations (TTM) was 59. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=131.152/1197.993
=0.10947643

ROA (Last Year)=Net Income/Total Assets (Mar24)
=100.932/961.953
=0.10492405

Medico Remedies's return on assets of this year was 0.10947643. Medico Remedies's return on assets of last year was 0.10492405. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medico Remedies's current Net Income (TTM) was 131. Medico Remedies's current Cash Flow from Operations (TTM) was 59. ==> 59 <= 131 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2.863/1366.013
=0.00209588

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=3.688/1079.973
=0.0034149

Medico Remedies's gearing of this year was 0.00209588. Medico Remedies's gearing of last year was 0.0034149. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1289.176/776.426
=1.66039777

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=966.751/569.615
=1.69720074

Medico Remedies's current ratio of this year was 1.66039777. Medico Remedies's current ratio of last year was 1.69720074. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medico Remedies's number of shares in issue this year was 83.008. Medico Remedies's number of shares in issue last year was 82.731. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=550.497/2063.773
=0.266743

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=426.11/1509.406
=0.2823031

Medico Remedies's gross margin of this year was 0.266743. Medico Remedies's gross margin of last year was 0.2823031. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2063.773/1197.993
=1.72269204

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1509.406/961.953
=1.56910577

Medico Remedies's asset turnover of this year was 1.72269204. Medico Remedies's asset turnover of last year was 1.56910577. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+0+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medico Remedies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Medico Remedies (NSE:MEDICO) has a Piotroski F-Score of 5 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medico Remedies and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Medico Remedies' Piotroski F-Score has ranged from 5.00 to 8.00. According to the industry distribution chart, Medico Remedies ranks #379 out of 981 companies in the Drug Manufacturers industry, placing it in the top 38.6%.
Is Medico Remedies' Piotroski F-Score too high?
Medico Remedies' current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Medico Remedies' value of 5 is 0% at this industry median. Based on the distribution chart, Medico Remedies ranks #379 out of 981 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Medico Remedies has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medico Remedies ranks #379 out of 981 companies for Piotroski F-Score. This puts Medico Remedies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Medico Remedies' value of 5 is 0% at this benchmark. Historically, Medico Remedies' own Piotroski F-Score has ranged from 5.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Medico Remedies has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medico Remedies's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medico Remedies and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medico Remedies's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹75.89, compared to a current price of ₹40.28 — trading 46.9% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Drug Manufacturers industry median of 5.00. Medico Remedies' overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Piotroski F-Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?

Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued. The current stock price of ₹40.28 is trading 46.9% below its estimated GF Value™ of ₹75.89. GuruFocus considers Medico Remedies to be Significantly Undervalued.

Key valuation signals for NSE:MEDICO:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: ₹75.89 vs. price of ₹40.28 (46.9% below fair value)
  • GF Score™: 87/100 with 2 warning signs
  • Industry Position: 0% at the Drug Manufacturers median (#379 of 981)

No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medico Remedies Business Description

Other Exchanges 540937:India
Address N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
87GF Score

Get the complete analysis for NSE:MEDICO

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.28
Price
₹75.89
GF Value